• Home
  • About Us
    • About Us
    • Subscribe
    • Privacy Policy
  • Advertise
    • Advertise On IP Watch
    • Editorial Calendar
  • Videos
  • Links
  • Help

Intellectual Property Watch

Original news and analysis on international IP policy

  • Copyright
  • Patents
  • Trademarks
  • Opinions
  • People News
  • Venues
    • Bilateral/Regional Negotiations
    • ITU/ICANN
    • United Nations – other
    • WHO
    • WIPO
    • WTO/TRIPS
    • Africa
    • Asia/Pacific
    • Europe
    • Latin America/Caribbean
    • North America
  • Themes
    • Access to Knowledge/ Open Innovation & Science
    • Food Security/ Agriculture/ Genetic Resources
    • Finance
    • Health & IP
    • Human Rights
    • Internet Governance/ Digital Economy/ Cyberspace
    • Lobbying
    • Technical Cooperation/ Technology Transfer
  • Health Policy Watch

Archives for February 2009

ISP Liability, Copyright Term Extension Key IP Issues For Europe This Year

18/02/2009 by Dugie Standeford for Intellectual Property Watch Leave a Comment

The effort to tackle digital piracy is likely to remain the most contentious intellectual property issue in Europe this year. It will be joined by debates on copyright term extension, IP provisions in trade agreements, and an ongoing discussion of patent policy in Europe.

Filed Under: IP Policies, Subscribers, Themes, Venues, Copyright Policy, Enforcement, English, Europe, Patents/Designs/Trade Secrets

WIPO Rules On jackass.com

18/02/2009 by Intellectual Property Watch Leave a Comment

It is often unfortunate to see what the public servants of the World Intellectual Property Organization domain name arbitration centre must sift through to make decisions on internet name disputes, which generally reflect consumer tastes. In this case, media industry giant Viacom lost its fight for the rights to jackass.com, which corresponds to its low-life […]

Filed Under: IP-Watch Briefs

Strong EU Trade Provisions On IP Seen As Threat To Poor Nations’ Medicines Access

18/02/2009 by David Cronin for Intellectual Property Watch 2 Comments

BRUSSELS – Efforts by the European Union to insert strong provisions on pharmaceutical patents in a series of free trade agreements it is negotiating could imperil access to medicines in developing countries, global public health activists have alleged.

As part of trade talks being conducted with India, Colombia, Peru and a regional grouping in south-east Asia, EU officials have proposed that drug-makers should benefit from a robust intellectual property regime. National regulatory authorities in the countries concerned would be prevented for lengthy periods from using data provided by a company that holds a drug patent in order to authorise a generic version of that medicine.

Filed Under: IP Policies, Language, News, Themes, Venues, Asia/Pacific, Bilateral/Regional Negotiations, Enforcement, English, Europe, Health & IP, Human Rights, Latin America/Caribbean, Patents/Designs/Trade Secrets, Technical Cooperation/ Technology Transfer, WTO/TRIPS

Texas Man Sentenced to 41 Months in Prison for Selling Counterfeit Software

18/02/2009 by Intellectual Property Watch Leave a Comment

WASHINGTON – Timothy Kyle Dunaway, 24, of Wichita Falls, Texas, was sentenced today to 41 months in prison by US District Court Judge Reed O’Connor in Wichita Falls for selling counterfeit computer software through the internet in violation of criminal copyright infringement laws, Acting Assistant Attorney General Rita M. Glavin of the Criminal Division and […]

Filed Under: IP-Watch Briefs

Intellectual Property Watch Website Updated

18/02/2009 by William New, Intellectual Property Watch Leave a Comment

Readers may have noticed a few changes to the Intellectual Property Watch website, which we hope will make us easier to use as we bring you the same great content like breaking and in-depth stories and expert views, plus new features like a microblog (the IP Burble), better subscription management, improved search capabilities, a new discussion forum, more podcasts and other products and services.

For those signed up to our RSS feed, you will need to update your feed reader with the following new feed address: http://feeds2.feedburner.com/ip-watch

For personal subscriptions, please always use your email address to login on the new website (your password is unchanged). If any doubt, you can request a new password below the login form.

If you are part of a group subscription, the administrator of your group has received or will receive new instructions.

If you have questions, email us at info@ip-watch.ch.

Filed Under: Editorials, Language, English

The Critical Amendments in Turkish Trademark Legislation

17/02/2009 by Intellectual Property Watch Leave a Comment

A Turkish firm, Grup Ofis Patents & Trademarks, has highlighted key concerns in Turkey’s new trademark legislation, which it said came into force in January 2009. Click here to read document.

Filed Under: IP-Watch Briefs

US Copyright Industry Submits On Special 301 Review

17/02/2009 by Intellectual Property Watch Leave a Comment

The International Intellectual Property Alliance, representing much of the US copyright industry, has submitted its allegations of foreign governments’ inadequate protection of US IP rights to the annual Special 301 process of the US Trade Representative’s office.  In all, 48 nations are named, and key targets again include China, Russia and Canada. IIPA release here […]

Filed Under: IP-Watch Briefs

US Congress, Lobbyists Renew Patent Reform Slog With Focus On Damages

17/02/2009 by Liza Porteus Viana, Intellectual Property Watch 2 Comments

With patent reform expected to be introduced sooner rather than later in this 111th United States Congress, calculating damages for infringement remains one of the main sticking points.

Filed Under: Features, IP Policies, Language, Themes, Venues, Biodiversity/Genetic Resources/Biotech, English, Health & IP, Information and Communications Technology/ Broadcasting, Innovation/ R&D, North America, Patents/Designs/Trade Secrets

GlaxoSmithKline CEO Calls For Patent Pool

13/02/2009 by Intellectual Property Watch Leave a Comment

Andrew Witty, CEO of pharmaceutical company GlaxoSmithKline, said in a speech Friday at Harvard Medical School that GSK will contribute to a patent pool intended to increase innovation on medicines for neglected diseases. A Reuters story on the event is available here.

Filed Under: IP-Watch Briefs

New Draft Ethiopian IP Law, Says Local Newspaper

13/02/2009 by Intellectual Property Watch Leave a Comment

The Ethiopian Intellectual Property Office (EIPO) has finished a draft intellectual property law that would help pave the way for fuller membership in the Geneva institutions, according to a local news source from the country. The unconfirmed article says EIPO will present the draft law to the Ethiopian government in the coming months.

Filed Under: IP-Watch Briefs, Access to Knowledge/ Education, English

  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next Page »
  • Email
  • Facebook
  • LinkedIn
  • RSS
  • Twitter
  • Vimeo
My Tweets

IPW News Briefs

Saudis Seek Alternative Energy Partners Through WIPO Green Program

Chinese IP Officials Complete Study Of UK, European IP Law

Perspectives on the US

In US, No Remedies For Growing IP Infringements

US IP Law – Big Developments On The Horizon In 2019

More perspectives on the US...

Supported Series: Civil Society And TRIPS Flexibilities

Civil Society And TRIPS Flexibilities Series – Translations Now Available

The Myth Of IP Incentives For All Nations – Q&A With Carlos Correa

Read the TRIPS flexibilities series...

Paid Content

Interview With Peter Vanderheyden, CEO Of Article One Partners

More paid content...

IP Delegates in Geneva

  • IP Delegates in Geneva
  • Guide to Geneva-based Public Health and IP Organisations

All Story Categories

Other Languages

  • Français
  • Español
  • 中文
  • اللغة العربية

Archives

  • Archives
  • Monthly Reporter

Staff Access

  • Writers

Sign up for free news alerts

This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy

Copyright © 2025 · Global Policy Reporting